BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 11955542)

  • 21. Diastolic arterial blood pressure: a reliable early predictor of survival in human septic shock.
    Benchekroune S; Karpati PC; Berton C; Nathan C; Mateo J; Chaara M; Riché F; Laisné MJ; Payen D; Mebazaa A
    J Trauma; 2008 May; 64(5):1188-95. PubMed ID: 18469640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemodynamic support in septic shock: is restoring a normal blood pressure the right target?
    Bracco D; Dubois MJ
    Crit Care Med; 2005 Sep; 33(9):2113-5. PubMed ID: 16148488
    [No Abstract]   [Full Text] [Related]  

  • 23. Terlipressin as a rescue therapy for catecholamine-resistant septic shock in children.
    Yildizdas D; Yapicioglu H; Celik U; Sertdemir Y; Alhan E
    Intensive Care Med; 2008 Mar; 34(3):511-7. PubMed ID: 18092150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Terlipressin as rescue therapy for intractable hypotension during neonatal septic shock.
    Matok I; Leibovitch L; Vardi A; Adam M; Rubinshtein M; Barzilay Z; Paret G
    Pediatr Crit Care Med; 2004 Mar; 5(2):116-8. PubMed ID: 14987339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical review: Vasopressin and terlipressin in septic shock patients.
    Delmas A; Leone M; Rousseau S; Albanèse J; Martin C
    Crit Care; 2005 Apr; 9(2):212-22. PubMed ID: 15774080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacology, clinical efficacy and safety of terlipressin in esophageal varices bleeding, septic shock and hepatorenal syndrome.
    Saner FH; Canbay A; Gerken G; Broelsch CE
    Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):207-17. PubMed ID: 19072411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Vasopressin and its analogues in the therapy of shock].
    Novák F; Lubanda H; Onderková R; Zák A
    Cas Lek Cesk; 2004; 143(5):307-8, 310-2. PubMed ID: 15305765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis.
    Avni T; Lador A; Lev S; Leibovici L; Paul M; Grossman A
    PLoS One; 2015; 10(8):e0129305. PubMed ID: 26237037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arginine vasopressin vs. terlipressin in the treatment of shock states.
    Singer M
    Best Pract Res Clin Anaesthesiol; 2008 Jun; 22(2):359-68. PubMed ID: 18683481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of terlipressin in the treatment of infants and neonates with catecholamine-resistant septic shock.
    Leone M; Martin C
    Best Pract Res Clin Anaesthesiol; 2008 Jun; 22(2):323-33. PubMed ID: 18683478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials.
    Serpa Neto A; Nassar AP; Cardoso SO; Manetta JA; Pereira VG; Espósito DC; Damasceno MC; Russell JA
    Crit Care; 2012 Aug; 16(4):R154. PubMed ID: 22889256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Terlipressin as rescue therapy in catecholamine-resistant hypotension in solid organ donors: a case report.
    Vecchiarelli P; Ricci F; Riccini T
    Transplant Proc; 2010; 42(1):203-5. PubMed ID: 20172313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Terlipressin: a promising vasoactive agent in hemodynamic support of septic shock.
    Morelli A; Ertmer C; Pietropaoli P; Westphal M
    Expert Opin Pharmacother; 2009 Oct; 10(15):2569-75. PubMed ID: 19735216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Refractory septic shock: efficacy and safety of very high doses of norepinephrine.
    Katsaragakis S; Kapralou A; Theodorou D; Markogiannakis H; Larentzakis A; Stamou KM; Drimousis P; Bramis I
    Methods Find Exp Clin Pharmacol; 2006 Jun; 28(5):307-13. PubMed ID: 16845448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vasopressin vs. terlipressin in the treatment of cardiovascular failure in sepsis.
    Lange M; Ertmer C; Westphal M
    Intensive Care Med; 2008 May; 34(5):821-32. PubMed ID: 18066524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early use of terlipressin in catecholamine-resistant shock improves cerebral perfusion pressure in severe traumatic brain injury.
    Salluh JI; Martins GA; Santino MS; Araújo LV; Freitas GG; Verdeal JC
    Acta Anaesthesiol Scand; 2007 Apr; 51(4):505-8. PubMed ID: 17378791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rescue therapy with terlipressin by continuous infusion in a child with catecholamine-resistant septic shock.
    Zeballos G; López-Herce J; Fernández C; Brandstrup KB; Rodríguez-Núñez A
    Resuscitation; 2006 Jan; 68(1):151-3. PubMed ID: 16325320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Addition of vasopressin to norepinephrine as independent predictor of mortality in patients with refractory septic shock: an observational study.
    Micek ST; Shah P; Hollands JM; Shah RA; Shannon WD; Kollef MH
    Surg Infect (Larchmt); 2007 Apr; 8(2):189-200. PubMed ID: 17437364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comment: Terlipressin for children with extremely low cardiac output after open heart surgery.
    Meyer S
    Ann Pharmacother; 2009 Jul; 43(7):1375-6; author reply 1376. PubMed ID: 19509348
    [No Abstract]   [Full Text] [Related]  

  • 40. Short-term effects of terlipressin bolus infusion on sublingual microcirculatory blood flow during septic shock.
    Morelli A; Donati A; Ertmer C; Rehberg S; Orecchioni A; Di Russo A; Pelaia P; Pietropaoli P; Westphal M
    Intensive Care Med; 2011 Jun; 37(6):963-9. PubMed ID: 21336777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.